⚠️ Heads up: Remdesivir is now going by a new name — ‘Veklury.
Some people say the renaming of Remdesivir to “Veklury” isn’t just a simple brand update—it could be a way for big pharmaceutical companies and regulators to reset public perception. The medicine was first rushed out during COVID-19 under an emergency use rule, and later the FDA gave it full approval as Veklury based on certain clinical data.
But many argue the evidence showing it helps isn’t as strong as claimed—some large international trials didn’t even find it reduced death rates fda.gov+6vox.com+6genengnews.com+6. Now, with a new name and shiny marketing, supporters push it as a go-to treatment, even though some experts still question its real-world benefits. The change could help doctors feel more comfortable using it, hospitals bill insurance, and Gilead keep earning large profits, all while doubts remain just beneath the surface.
Wasn't Remdesivir used to treat AIDS?
Remdesivir was not originally developed to treat AIDS (which is caused by the HIV virus), but this is a common confusion because it is an antiviral drug and shares some similarities with HIV treatments in how it works.
Here’s the real story:
What Remdesivir Was Actually Made For
Remdesivir was first developed by the drug company Gilead Sciences to treat Ebola during the 2014–2016 outbreak in West Africa. It didn't work well enough in human trials for Ebola, but scientists noticed that it had strong effects against other viruses in lab tests, including coronaviruses like SARS and MERS.
Why People Link It to HIV/AIDS
Gilead Sciences—the company that created Remdesivir—is also the maker of Truvada and other HIV/AIDS medications. Because both HIV drugs and Remdesivir are antiviral medications and come from the same company, people often assume Remdesivir was part of the HIV treatment plan. But it wasn’t designed for HIV and hasn’t been approved to treat it.
How It Works (In Simple Terms)
Remdesivir tries to stop viruses from copying their RNA—this is like stopping a printer from printing more virus instructions inside the body. HIV drugs also mess with how viruses copy themselves, but they target different steps. So the similarity is in the general idea, not the disease it was meant to treat.
What This Means
-
FDA Approval
In October 2020, the FDA gave full approval to what was initially known as Remdesivir under emergency use. It's now branded Veklury and remains the only antiviral approved for COVID-19 patients in hospitals youtube.com+11fda.gov+11interestingengineering.com+11. -
How It Works
Veklury blocks the coronavirus’s ability to copy itself, helping some patients recover faster—about 5 days quicker on average during clinical trials europeanpharmaceuticalreview.com. -
Effectiveness Debates
Some studies, including a big WHO trial, found little impact on survival. Others showed benefits in reducing hospital stays and progression of disease vox.com. -
New Name = New Era
Bringing Remdesivir under full FDA approval and marketing it as "Veklury" has helped give it broader doctor confidence, insurance coverage, and financial return for Gilead, even as questions remain about its long-term value.
Comments
Post a Comment